Statistics

Total Visits

Views
Clinical experience of bosutinib under compasionate use program in chronic myeloid leukemia patients with resistance or intolerance to imatinib, dasatinib and nilotinib65

Select a period of time:

Number of views in the range

Views
Clinical experience of bosutinib under compasionate use program in chronic myeloid leukemia patients with resistance or intolerance to imatinib, dasatinib and nilotinib26

Views

Views
July 202514
August 20250
September 20254
October 20255
November 20251
December 20252
January 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Brazil7
Germany2
Costa Rica1
Ecuador1
United Kingdom1
Peru1
South Africa1
 

Top cities views

Views
Aracaju1
Ashburn1
Beeville1
Brasília1
Canoas1
Contagem1
Dallas1
Ephrata1
Frankfurt am Main1
Lima1